Cite
HARVARD Citation
Fritz, S. et al. (2016). A phase I clinical study to evaluate safety of orally administered, genetically engineered Salmonella enterica serovar Typhimurium for canine osteosarcoma. Veterinary medicine and science. 2 (3), pp. 179-190. [Online].